Meditation Based Lifestyle Modification in Chronic Pain
MBLM-P
1 other identifier
interventional
22
1 country
1
Brief Summary
MBLM is a holistic therapy for people with mental disorders whose feasibility positive effects on patients with depression have already been demonstrated in clinical application and a piloted study. In the present trial, the feasibility and effect of MBLM on patients with chronic pain will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2019
CompletedFirst Submitted
Initial submission to the registry
September 7, 2019
CompletedFirst Posted
Study publicly available on registry
September 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedJuly 28, 2020
July 1, 2020
5 months
September 7, 2019
July 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain VAS
Visual Analog Scale for Pain
through study completion, daily for around 3 months
Pain medication
Use of pain medication
through study completion, daily for around 3 months
Well-Being
The WHO-5 Well-Being Scale (WHO-5; World Health Organisation, 1998)
through study completion, daily for around 3 months
Secondary Outcomes (5)
Emotion Regulation
through study completion, weekly for around 3 months
Body awareness
through study completion, twice weekly for around 3 months
Mind-Wandering
through study completion, weekly for around 3 months
Depression, Anxiety & Stress
through study completion, weekly for around 3 months
Pain Self Efficacy
through study completion, weekly for around 3 months
Other Outcomes (6)
Quality of Life
at week 0 and week 11
Chronic Pain Self-Efficacy
at week 0 and week 11
Distress Tolerance
at week 0 and week 11
- +3 more other outcomes
Study Arms (3)
Baseline 10 Days
EXPERIMENTAL10 days baseline before intervention starts.
Baseline 17 Days
EXPERIMENTAL17 days baseline before intervention starts.
Baseline 24 Days
EXPERIMENTAL24 days baseline before intervention starts.
Interventions
Eligibility Criteria
You may qualify if:
- Outpatients
- Current diagnosis of a chronic pain disorder.
- Over 18 years old.
- Physically able to perform simple yoga postures and sit for 20 minutes.
- Have given your written consent to participate in the study.
You may not qualify if:
- Psychotic symptoms
- Acute suicidality
- obsessive-compulsive disorder
- Cerebro-organic diseases with clinically relevant symptoms
- Severe multimorbidity
- Current participation in another meditation or yoga study
- Regular meditation or yoga practice (\> once a week in the last 6 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diakonie Kliniken Zschadraßlead
- Chemnitz University of Technologycollaborator
- Technische Universität Dresdencollaborator
Study Sites (1)
Diakoniekliniken Zschadraß
Colditz, Saxony, 04680, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 7, 2019
First Posted
September 13, 2019
Study Start
September 2, 2019
Primary Completion
January 31, 2020
Study Completion
January 31, 2020
Last Updated
July 28, 2020
Record last verified: 2020-07